These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 34384142)

  • 1. Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy.
    Anderson LL; Heblinski M; Absalom NL; Hawkins NA; Bowen MT; Benson MJ; Zhang F; Bahceci D; Doohan PT; Chebib M; McGregor IS; Kearney JA; Arnold JC
    Br J Pharmacol; 2021 Dec; 178(24):4826-4841. PubMed ID: 34384142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+/- mouse model of Dravet syndrome.
    Anderson LL; Bahceci DA; Hawkins NA; Everett-Morgan D; Banister SD; Kearney JA; Arnold JC
    PLoS One; 2023; 18(1):e0280842. PubMed ID: 36701411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olivetolic acid, a cannabinoid precursor in Cannabis sativa, but not CBGA methyl ester exhibits a modest anticonvulsant effect in a mouse model of Dravet syndrome.
    Anderson LL; Udoh M; Everett-Morgan D; Heblinski M; McGregor IS; Banister SD; Arnold JC
    J Cannabis Res; 2022 Jan; 4(1):2. PubMed ID: 34980287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome.
    Anderson LL; Low IK; Banister SD; McGregor IS; Arnold JC
    J Nat Prod; 2019 Nov; 82(11):3047-3055. PubMed ID: 31686510
    [No Abstract]   [Full Text] [Related]  

  • 5. Beyond CBD: Inhibitory effects of lesser studied phytocannabinoids on human voltage-gated sodium channels.
    Milligan CJ; Anderson LL; McGregor IS; Arnold JC; Petrou S
    Front Physiol; 2023; 14():1081186. PubMed ID: 36891145
    [No Abstract]   [Full Text] [Related]  

  • 6. Cannabichromene, Related Phytocannabinoids, and 5-Fluoro-cannabichromene Have Anticonvulsant Properties in a Mouse Model of Dravet Syndrome.
    Anderson LL; Ametovski A; Lin Luo J; Everett-Morgan D; McGregor IS; Banister SD; Arnold JC
    ACS Chem Neurosci; 2021 Jan; 12(2):330-339. PubMed ID: 33395525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between cannabidiol and Δ
    Anderson LL; Low IK; McGregor IS; Arnold JC
    Br J Pharmacol; 2020 Sep; 177(18):4261-4274. PubMed ID: 32608111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions.
    Anderson LL; Absalom NL; Abelev SV; Low IK; Doohan PT; Martin LJ; Chebib M; McGregor IS; Arnold JC
    Epilepsia; 2019 Nov; 60(11):2224-2234. PubMed ID: 31625159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anticonvulsant phytocannabinoids CBGVA and CBDVA inhibit recombinant T-type channels.
    Udoh M; Bladen C; Heblinski M; Luo JL; Janve VS; Anderson LL; McGregor IS; Arnold JC
    Front Pharmacol; 2022; 13():1048259. PubMed ID: 36386164
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the Possible Anticonvulsant Effect of Δ
    Benson MJ; Anderson LL; Low IK; Luo JL; Kevin RC; Zhou C; McGregor IS; Arnold JC
    Cannabis Cannabinoid Res; 2022 Feb; 7(1):46-57. PubMed ID: 33998858
    [No Abstract]   [Full Text] [Related]  

  • 12. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
    Devinsky O; Cilio MR; Cross H; Fernandez-Ruiz J; French J; Hill C; Katz R; Di Marzo V; Jutras-Aswad D; Notcutt WG; Martinez-Orgado J; Robson PJ; Rohrback BG; Thiele E; Whalley B; Friedman D
    Epilepsia; 2014 Jun; 55(6):791-802. PubMed ID: 24854329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome.
    Kaplan JS; Stella N; Catterall WA; Westenbroek RE
    Proc Natl Acad Sci U S A; 2017 Oct; 114(42):11229-11234. PubMed ID: 28973916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol reveals a disruptive strategy for 21st century epilepsy drug discovery.
    Del Pozo A; Barker-Haliski M
    Exp Neurol; 2023 Feb; 360():114288. PubMed ID: 36471511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies.
    Reddy DS
    Exp Neurol; 2023 Jan; 359():114237. PubMed ID: 36206806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
    Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA
    PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.
    Golub V; Reddy DS
    Adv Exp Med Biol; 2021; 1264():93-110. PubMed ID: 33332006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Source of cannabinoids: what is available, what is used, and where does it come from?
    Specchio N; Pietrafusa N; Cross HJ
    Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome.
    Lattanzi S; Trinka E; Striano P; Rocchi C; Salvemini S; Silvestrini M; Brigo F
    CNS Drugs; 2021 Mar; 35(3):265-281. PubMed ID: 33754312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis constituents reduce seizure behavior in chemically-induced and scn1a-mutant zebrafish.
    Thornton C; Dickson KE; Carty DR; Ashpole NM; Willett KL
    Epilepsy Behav; 2020 Sep; 110():107152. PubMed ID: 32585475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.